Thursday, August 03, 2023 11:36:46 AM
Recent ALLO News
- Allogene Therapeutics Awarded Grant from the California Institute for Regenerative Medicine to Advance Development of an Allogeneic CAR T in Renal Cell Carcinoma • GlobeNewswire Inc. • 04/26/2024 12:30:00 PM
- Allogene Therapeutics Announces Q2 Investor Conference Participation • GlobeNewswire Inc. • 04/09/2024 12:30:00 PM
- Allogene Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Update • GlobeNewswire Inc. • 03/14/2024 08:05:00 PM
- Allogene Therapeutics and Arbor Biotechnologies Announce Global Gene Editing Licensing Agreement to Support Advancement of Next-Generation Allogeneic CAR T Platform in Autoimmune Disease • GlobeNewswire Inc. • 03/12/2024 12:30:00 PM
- Allogene Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update • GlobeNewswire Inc. • 03/05/2024 01:30:00 PM
- Allogene Therapeutics Announces Participation in the 44th Annual TD Cowen Health Care Conference • GlobeNewswire Inc. • 02/28/2024 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 01:30:30 PM
- Allogene Therapeutics to Restate Previously Filed Financial Statements Recognizing Non-Cash Accounting Adjustments Related to the December 2020 Formation of the Allogene Overland Biopharm Joint Venture in Asia • GlobeNewswire Inc. • 02/16/2024 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 10:45:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/24/2024 10:25:04 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/22/2024 09:11:45 PM
- Allogene Therapeutics Announces Participation in Upcoming Investor Conferences • GlobeNewswire Inc. • 01/16/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 01:00:31 PM
- Allogene Therapeutics and Foresight Diagnostics Announce Partnership to Develop MRD-based In-Vitro Diagnostic for Use in ALPHA3, the First Pivotal Trial for Frontline Consolidation in Large B-Cell Lymphoma • GlobeNewswire Inc. • 01/04/2024 09:15:00 PM
- Allogene Therapeutics Announces 2024 Platform Vision to Redefine the Future of CAR T Led by ALPHA3, the Industry's First Pivotal Trial for Frontline Consolidation in Large B-Cell Lymphoma • GlobeNewswire Inc. • 01/04/2024 09:05:00 PM
- Allogene Therapeutics to Host Conference Call Previewing its 2024 Platform Vision and Present at the 42nd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/03/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/20/2023 09:26:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2023 08:46:25 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/18/2023 09:17:30 PM
- Allogene Therapeutics Presents Comprehensive Safety Data of Proprietary Lymphodepletion Agent ALLO-647 at the 65th Annual Meeting of the American Society of Hematology • GlobeNewswire Inc. • 12/09/2023 05:00:00 PM
- Allogene Therapeutics Announces Participation in December Investor Conference • GlobeNewswire Inc. • 12/01/2023 01:30:00 PM
- Allogene Therapeutics Presents Preclinical Data on Next Generation Cloak™ and Dagger™ Technologies at the Society for Immunotherapy of Cancer Annual Meeting • GlobeNewswire Inc. • 11/03/2023 04:00:00 PM
- Allogene Therapeutics Presents Preclinical Data on a Novel Allogeneic CAR T Product Candidate Targeting Claudin18.2 at the Society for Immunotherapy of Cancer Annual Meeting • GlobeNewswire Inc. • 11/03/2023 04:00:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/02/2023 08:41:20 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/02/2023 08:06:51 PM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM